Know Cancer

or
forgot password

Long-Term Temporary Drainage of Malignant Extrinsic Ureteral Obstruction Secondary to Inoperable Pelvic or Abdominal Malignancies Using the Memokath 051 Ureteral Stent


N/A
18 Years
N/A
Not Enrolling
Both
Ureteral Obstruction

Thank you

Trial Information

Long-Term Temporary Drainage of Malignant Extrinsic Ureteral Obstruction Secondary to Inoperable Pelvic or Abdominal Malignancies Using the Memokath 051 Ureteral Stent


Inclusion Criteria:



- Presence of extrinsic ureteral obstruction secondary to inoperable pelvic or
abdominal malignancy.

- Life expectancy greater than 4 months.

- Adult patient (18 years of age or older)

- Preoperative medical examination clearing the patient for general anesthesia

- No active urinary tract infection by urinalysis and urine culture

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Treatment efficacy in relief of extrinsic ureteral obstruction in comparison to historic efficacy of standard double-J plastic ureteral stents as cited in the urologic literature

Outcome Time Frame:

baseline to 12 months

Safety Issue:

Yes

Principal Investigator

Lance A Mynderse, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Mayo Clinic

Authority:

United States: Food and Drug Administration

Study ID:

255-03

NCT ID:

NCT00166361

Start Date:

March 2004

Completion Date:

November 2008

Related Keywords:

  • Ureteral Obstruction
  • Ureteral Obstruction

Name

Location

Mayo ClinicRochester, Minnesota  55905